Clinical Trials Logo

Clinical Trial Summary

This is an international, multi-center study to determine the efficacy, safety, and tolerability of romosozumab (AMG 785) in adults with a fresh unilateral hip fracture, status post surgical fixation.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT01081678
Study type Interventional
Source Amgen
Contact
Status Completed
Phase Phase 2
Start date June 20, 2010
Completion date May 10, 2013

See also
  Status Clinical Trial Phase
Terminated NCT00548496 - A Phase IIa Study Of Men And Post-Menopausal Women With A Fractured Distal Radius Phase 2
Completed NCT00907296 - Study of Romosozumab (AMG 785) in Tibial Diaphyseal Fractures Status Post Intramedullary Nailing Phase 2
Completed NCT03286270 - A mRUS Validation Study for Nail-treated Fractures of Long Bones and a TUS Exploratory Study for Nail and Plate-treated Fractures of Long Bones
Not yet recruiting NCT04533984 - Fracture Recovery for Returning to Duty (Teriparatide STRONG) Phase 4
Recruiting NCT03232216 - Vitamin D Supplementation and Tibia Fracture. Does it Improve Healing Rate? N/A
Recruiting NCT04941612 - Use of the Bioabsorbable Activa IM-Nailâ„¢ in Pediatric Diaphyseal Forearm Fractures N/A
Recruiting NCT01070576 - Arginine and Nitric Oxide (NO) Early Prognostic Markers for Non-union Development N/A
Recruiting NCT05825079 - Does Weightbearing Crutch Technology Impact Patient Compliance? N/A
Recruiting NCT03871322 - The Vitamin K2 and D3 Intervention Trial in Children and Adolescents With the Low-energy Fractures N/A
Terminated NCT00435877 - Procurement of Tissue Samples for Cell Cultures and Analyses
Completed NCT04783337 - Local Remodelling of Bone Fracture Healing N/A